First Time Loading...

Dolby Laboratories Inc
NYSE:DLB

Watchlist Manager
Dolby Laboratories Inc Logo
Dolby Laboratories Inc
NYSE:DLB
Watchlist
Price: 81.74 USD 2.55% Market Closed
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

2.9B
-1%
Assets
Growth Rates:
1 Year
+7%
3 Years
-5%
5 Years
+4%
7 Years
+26%
10 Years
+66%
589.7m
-6%
Liabilities
Growth Rates:
1 Year
+28%
3 Years
+11%
5 Years
+23%
7 Years
+75%
10 Years
+150%
2.3B
-0.4%
Equity
Growth Rates:
1 Year
+3%
3 Years
-9%
5 Years
+0%
7 Years
+18%
10 Years
+53%

Balance Sheet Decomposition
Dolby Laboratories Inc

2.9B
Assets
589.7m
Liabilities
2.9B
Assets
589.7m
Liabilities
Current Assets 1.5B
Cash & Short-Term Investments 797.6m
Receivables 510.8m
Other Current Assets 142.9m
Non-Current Assets 1.5B
Long-Term Investments 92.9m
PP&E 517.3m
Intangibles 570.3m
Other Non-Current Assets 303.6m
Current Liabilities 394.1m
Accounts Payable 14.4m
Accrued Liabilities 168.5m
Other Current Liabilities 211.2m
Non-Current Liabilities 195.6m
Other Non-Current Liabilities 195.6m

Balance Sheet
Dolby Laboratories Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
569
532
516
627
918
797
1 072
1 225
620
745
Cash Equivalents
569
532
516
627
918
797
1 072
1 225
620
745
Short-Term Investments
231
139
122
248
178
119
47
39
189
139
Total Receivables
90
112
77
76
335
386
342
415
420
444
Accounts Receivables
86
102
76
74
332
385
342
415
420
444
Other Receivables
4
11
1
2
2
1
0
0
0
0
Inventory
9
14
16
25
26
32
26
11
24
36
Other Current Assets
107
24
29
35
40
47
61
70
58
123
Total Current Assets
1 006
821
760
1 011
1 497
1 382
1 547
1 761
1 311
1 488
PP&E Net
290
403
444
485
514
537
619
602
560
522
PP&E Gross
290
403
444
485
514
537
619
602
560
522
Accumulated Depreciation
171
202
251
305
362
417
476
538
558
577
Intangible Assets
64
128
215
190
184
181
152
123
112
167
Goodwill
278
308
310
311
328
335
337
341
365
408
Long-Term Investments
296
321
394
314
188
180
52
63
103
98
Other Long-Term Assets
51
153
188
222
155
208
210
217
239
297
Other Assets
278
308
310
311
328
335
337
341
365
408
Total Assets
1 984
N/A
2 133
+8%
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
Liabilities
Accounts Payable
16
21
18
14
22
15
13
18
14
21
Accrued Liabilities
115
129
135
158
174
209
175
205
180
215
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
59
60
61
74
89
82
79
93
83
187
Total Current Liabilities
189
210
213
246
285
307
267
316
278
422
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Minority Interest
22
9
9
7
7
6
6
6
5
17
Other Liabilities
63
108
118
144
210
202
212
186
161
185
Total Liabilities
274
N/A
326
+19%
340
+4%
397
+17%
502
+26%
514
+3%
485
-6%
508
+5%
443
-13%
625
+41%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
1 661
1 801
1 938
2 083
2 314
2 328
2 443
2 608
2 298
2 392
Additional Paid In Capital
46
18
42
61
66
0
0
0
0
0
Unrealized Security Profit/Loss
1
0
1
0
3
2
1
0
6
3
Other Equity
3
12
11
7
13
23
11
10
46
34
Total Equity
1 710
N/A
1 807
+6%
1 970
+9%
2 137
+8%
2 364
+11%
2 307
-2%
2 433
+5%
2 598
+7%
2 246
-14%
2 355
+5%
Total Liabilities & Equity
1 984
N/A
2 133
+8%
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
Shares Outstanding
Common Shares Outstanding
102
101
101
102
103
100
100
101
96
96

See Also

Summary
DLB intrinsic value, competitors valuation, and company profile.
DCF Valuation
DLB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DLB stock valuation using valuation multiples.
Wall Street Estimates
DLB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DLB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.